SEOUL, May 23 (Korea Bizwire) — South Korean vaccine maker SK Bioscience Co. said Monday it has secured a US$31.3 million deal from the Pan American Health Organization (PAHO) to supply chickenpox vaccines to Latin American countries. SK Bioscience said it has recently delivered its first batch of shipments of SKY Varicella, the company’s chickenpox [...]
SEOUL, May 23 (Korea Bizwire) — The Ministry of Health and Welfare announced that it had selected four hospitals to participate in an initiative to develop new smart hospital services. The project is aimed at developing and verifying a leading model to improve patient safety and medical service quality by leveraging information and communications technology [...]
SEOUL, May 17 (Korea Bizwire) — South Korea plans to conduct tests for COVID-19 antibody positivity this month to secure scientific data for pandemic-related policies, health officials said Tuesday. The state-run National Institute of Infectious Diseases will test a selected pool of 10,000 people aged 5 and above across the country later this month to [...]
SEOUL, May 13 (Korea Bizwire) — South Korea’s Lotte Group decided Friday to buy U.S. drug firm Bristol Myers Squibb (BMS)’s pharmaceutical factory in Syracuse, New York, for $160 million. Lotte’s board of directors approved the deal, which also includes BMS’s contract manufacturing agreements to produce medicine worth $220 million over the next three years. [...]
SEOUL, May 9 (Korea Bizwire) — Seniors with dementia have seen their symptoms worsen at a much faster rate after being cut off from society during the pandemic era. Choi Ho-jin, a professor of neurology at Hanyang University Guri Hospital led a team that published an article in Dementia and Neurocognitive Disorders, a journal published [...]
SEOUL, May 3 (Korea Bizwire) — South Korean drug and biotechnology companies are speeding up efforts to explore new growth engines to cope with the shift of COVID-19 from pandemic to endemic. Pharmaceutical giant Celltrion Inc. aims to launch its autoimmune disease biosimilar Yuflyma in the United States this year. It also made an equity [...]
SEOUL, April 27 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Wednesday it will begin sales of its autoimmune disease biosimilar Yuflymain in the United States in July 2023. The plan comes as Celltrion has settled a patent dispute with U.S. drugmaker AbbVie Inc. Yuflyma — a biosimilar referencing blockbuster drug Humira — [...]
SEOUL, April 26 (Korea Bizwire) — South Korea has developed a new molecular diagnosis technology that can detect not only COVID-19 but also other future viruses in a rapid and accurate manner. The National Research Foundation of Korea said Monday that researchers at Konkuk University had succeeded in developing a molecular diagnosis procedure that can [...]
SEOUL, April 22 (Korea Bizwire) — SD Biosensor Inc., a South Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won (US$49.8 million) in an effort to tap deeper into the European market. The contract calls for SD Biosensor to acquire [...]
SEOUL, April 21 (Korea Bizwire) – The number of obese people in South Korea more than doubled between 2017 and 2021, a trend exacerbated by the coronavirus pandemic, data showed Thursday. According to the Health Insurance Review and Assessment Service, the number of overweight patients increased from 14,966 in 2017 to 31,170 last year. The [...]